People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses.
J Infect Dis
; 227(7): 838-849, 2023 04 12.
Article
en En
| MEDLINE
| ID: mdl-35668700
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Infecciones por VIH
/
COVID-19
Idioma:
En
Revista:
J Infect Dis
Año:
2023
Tipo del documento:
Article